Correvio Pharma Corp.(Toronto Stock Exchange : CRME)
(
)
CRME PreMarket:
$
()
as of AM
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Message Boards
...
News
...
Health Technology » Biotechnology
Company Profile
Correvio Pharma Corp. is a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. It focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients, and healthcare systems. The company was founded on December 12, 1986 and is headquartered in Vancouver, Canada.